Citizens JMP analyst Matthew Carletti raised the firm’s price target on Bowhead Specialty (BOW) to $40 from $38 and keeps an Outperform rating on the shares. The firm expects Q1 results to be highlighted by catastrophe losses and ongoing concerns around casualty loss reserves, while tariff uncertainty and the possible impacts on inflation will likely also be a key focus, the analyst tells investors in a research note.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BOW:
- Bowhead Specialty price target lowered to $33 from $34 at Morgan Stanley
- Bowhead Specialty price target lowered to $43 from $44 at Keefe Bruyette
- Bowhead Specialty price target raised to $35 from $30 at JPMorgan
- Bowhead Specialty upgraded to Outperform from Market Perform at Keefe Bruyette
- Bowhead Specialty Highlights Profitable Growth in E&S Market
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue